Genome Biologics is a startup.
Genome Biologics develops therapeutic targets and discovers drugs for cardiovascular and cardiometabolic diseases, using integrated technology platforms to accelerate the development of novel therapies for conditions with limited or no existing treatments.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.